Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RELA | Q04206 | 1/20 | 0.56 |
| ▸ | CYP1A1 | P04798 | 5/20 | 0.54 |
| ▸ | CYP1B1 | Q16678 | 5/20 | 0.54 |
| ▸ | ESR1 | P03372 | 4/20 | 0.54 |
| ▸ | ALOX5 | P09917 | 4/20 | 0.54 |
| ▸ | PTGS2 | P35354 | 4/20 | 0.54 |
| ▸ | NQO2 | P16083 | 4/20 | 0.54 |
| ▸ | TTR | P02766 | 3/20 | 0.54 |
| ▸ | TUBB4A | P04350 | 3/20 | 0.54 |
| ▸ | TUBB | P07437 | 3/20 | 0.54 |
| ▸ | TUBA3C | P0DPH7 | 3/20 | 0.54 |
| ▸ | TUBA1B | P68363 | 3/20 | 0.54 |
| ▸ | TUBA4A | P68366 | 3/20 | 0.54 |
| ▸ | TUBB4B | P68371 | 3/20 | 0.54 |
| ▸ | TUBB3 | Q13509 | 3/20 | 0.54 |
| ▸ | TUBB2A | Q13885 | 3/20 | 0.54 |
| ▸ | TUBB8 | Q3ZCM7 | 3/20 | 0.54 |
| ▸ | TUBA3E | Q6PEY2 | 3/20 | 0.54 |
| ▸ | TUBA1A | Q71U36 | 3/20 | 0.54 |
| ▸ | TUBA1C | Q9BQE3 | 3/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15024181 | 0.91 | RELA (0.56) | RELACYP1A1CYP1B1ESR1ALOX5 | |
| SCHEMBL16419899 | 0.90 | PTGS2 (0.68) | RELACYP1A1CYP1B1ESR1ALOX5 | |
| SCHEMBL10012622 | 0.88 | CYP1A1 (0.73) | RELACYP1A1CYP1B1ESR1ALOX5 | |
| SCHEMBL9927130 | 0.84 | TUBB4A (0.75) | CYP1A1CYP1B1ESR1ALOX5PTGS2 | |
| SCHEMBL14665732 | 0.83 | PTGS2 (0.62) | RELACYP1A1CYP1B1ESR1ALOX5 | |
| SCHEMBL15096130 | 0.83 | CYP1A1 (0.67) | CYP1A1CYP1B1ESR1ALOX5PTGS2 | |
| SCHEMBL13984043 | 0.83 | CYP1A1 (0.77) | RELACYP1A1CYP1B1ESR1ALOX5 | |
| SCHEMBL12667489 | 0.83 | CYP1A1 (0.77) | RELACYP1A1CYP1B1ESR1ALOX5 | |
| SCHEMBL14227630 | 0.81 | TTR (0.64) | CYP1A1CYP1B1ESR1ALOX5PTGS2 | |
| SCHEMBL12729821 | 0.80 | PTGS2 (0.80) | RELACYP1A1CYP1B1ESR1ALOX5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230172947-A1 | METHODS AND COMPOSITIONS FOR TREATING ENDOMETRIAL CANCER | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2023-06-08 | — | — | US | disclosed |
| US-20180035705-A1 | COMPOSITIONS PROVIDING EXTENDED ENERGY AND METHODS OF USE | BLUE DRAGONFLY, INC. (US) | 2018-02-08 | — | — | US | disclosed |
| US-20170080037-A1 | Compositions for Regulation and Control of Appetite | Therapeutic Solutions LLC | 2017-03-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230172947-A1 | METHODS AND COMPOSITIONS FOR TREATING ENDOMETRIAL CANCER | HSD17B11, CYP19A1, NR5A1 | RELA 1864/4885CYP1A1 1670/4885CYP1B1 543/4885 |
| US-20170080037-A1 | Compositions for Regulation and Control of Appetite | FABP6, TAS2R60, TAS2R40 | RELA 2866/4885CYP1A1 2990/4885CYP1B1 2733/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.